Randomized control trial of the conditioning BUCy regimen with fludarabincin instead of cyclophosphamide in allogeneic hematopoietic stem cell transplantation from identical siblings.

Trial Profile

Randomized control trial of the conditioning BUCy regimen with fludarabincin instead of cyclophosphamide in allogeneic hematopoietic stem cell transplantation from identical siblings.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2013

At a glance

  • Drugs Fludarabine (Primary) ; Busulfan; Cyclophosphamide; Cytarabine
  • Indications Graft-versus-host disease; Haematological malignancies
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2012 Results presented at the 17th Congress of the European Haematology Association.
    • 21 May 2012 Planned end date changed from 1 Aug 2010 to 30 Dec 2010 as reported by Chinese Clinical Trial Register record.
    • 01 Sep 2009 Status changed from suspended to recruiting as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top